ANRESIS, the Swiss Centre for Antibiotic Resistance is a nationwide, representative surveillance system and research instrument for antibiotic resistance and consumption. It is hosted by the Institute for Infectious Diseases (IFIK) of the University of Bern and is financially supported by the Swiss Federal Office of Public Health (FOPH) and the IFIK.
News
Follow us on LinkedIn
What does the AMR situation in India look like – and how is Switzerland connected? A compelling report by SRF’s Trendmagazine explores the global dynamics of antimicrobial resistance (in German).
A new study based on ANRESIS data shows an association between antimicrobial consumption and C. difficile incidence in a Swiss medical centre. http://www.anresis.ch/wp-content/uploads/2025/06/2025_cdiff_infect-prev_wassilew.pdf
ANRESIS participated in this year’s #ESCMID Global Congress, presenting research on outpatient antibiotic use (https://www.anresis.ch/wp-content/uploads/2025/04/ESCMID2025_SASIS_Habegger.pdf), Candida infections (https://www.anresis.ch/wp-content/uploads/2025/04/ECCMID_2025_Antimycotics_Friedli.pdf), and nosocomial respiratory pathogens (https://www.anresis.ch/wp-content/uploads/2025/04/TBS_Sommerstein_final.pdf).
ANRESIS continuously collects all anonymized resistance data that is generated in routine diagnostics from
ANRESIS is supported by the following Organisations
